NCT04751747View on ClinicalTrials.gov

Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

February 1, 2024

Study Completion Date

September 1, 2025

Conditions
Locally Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8Unresectable Lung Non-Small Cell Carcinoma
Interventions
PROCEDURE

Computed Tomography

Undergo CT simulation

OTHER

Contrast Agent

Given IV

Trial Locations (2)

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

RECRUITING

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Rutgers, The State University of New Jersey

OTHER